protein
| FOG1 (in both megakaryocyte and erythrocyte development |
|
interacting with ZNF145, coactivating thrombopoetin receptor and inducing megakaryocyte development |
|
binding to the beta-globin locus |
|
mediating with NFE2 the erythrocyte expression of alpha-spectrin |
|
with Sp1 or EKLF (may play a crucial role in bringing regulatory elements such as enhancers in proximity to promoters by promoting the formation of DNA loops) |
|
interacting with MED1(acting as a coactivator in erythroid development) |
|
interacting with SPI1 (Ets domain of SPI1 and the GATA1 C-terminal zinc finger (CF) form a low affinity interaction in which specific regions of each protein are implicated) |
|
GATA1 specifically associates with BCL11A in erythroid cells |
|
combinatorial effect of Ikaros and GATA1 impairs close proximity between the locus control region and the gamma-globin genes and might represent an important mechanism of gene regulation during hematopoiesis |
|
direct interaction of GATA1 with EHZF was demonstrated(EHZF modulates erythroid cell differentiation through direct binding with GATA1) |
|
direct transcriptional target of TAp73alpha |
|
HMG2B potentiates GATA1-dependent transcription of GFI1B by POU5F1 and thereby controls erythroid differentiation |
|
interaction between GATA1 and ZFPM1 is critical for the development of both erythroid and megakaryocytic cell lineages |
|
functional relationship between GATA1 and DMRT1, coexpressed in Sertoli cells |
|
is a functionally important target gene of SUPT5H |
|
interacting with BRD3, and this interaction is essential for the targeting of GATA1 to chromatin |
|
BRD3 binds via its first bromodomain (BD1) to GATA1 in an acetylation-dependent manner |
|
GATA1 and its cofactor ZFPM1 are required for the differentiation of erythrocytes and megakaryocytes |
|
exogenous expression of ZFPM1 in mast cells leads to displacement of GATA1 from mast cell-specific genes and causes their downregulation |
|
utilizes IKAROS and polycomb repressive complex 2 to suppress HES1 and to promote erythropoiesis |
|
GATA2 and GATA1 positively and negatively control human IL1RL1 gene transcription, respectively and are involved in IL1RL1 transcription levels in primary basophils maintained in the presence of IL3 |
|
CDC6 expression is regulated by lineage-specific transcription factor GATA1 |
|
GATA1 coregulators ZFPM1 and TAL1 dissociate from mitotic chromatin, suggesting that GATA1 functions as platform for their postmitotic recruitment |
|
CEBPA and/or GATA1 directly suppress the expression of DACH1 through binding to the promoter region |
|
TAL1 associates with GATA1, GATA2, lim-only protein LMO2, and LDB1 in a multimeric complex to regulate erythroid transcription |
|
TAL1 can recruit GATA1 and increase GATA1 binding to the EPOR promoter region to stimulate gene expression |
|
MED1 is a context-dependent GATA1 coregulator, and also exerts specialized functions in erythroid cells to control GATA1-independent, cell-type-specific genes, which include candidate regulators of erythroid cell development and function |
|
GATA1-dependent looping mechanisms may facilitate the conservation of TAL1 regulation despite cis-regulatory remodeling during vertebrate evolution |
|
PSTPIP2 is a GATA1-repressed gene that controls megakaryopoiesis |
|
GATA1 and TAL1 are bound to the regulatory regions of TFDP2 and upregulate its expression |
|
SPI1 and GATA1 transactivate FCER1A |
|
GATA1/FOXO3 repressed expression of EXOSC8, a pivotal component of the exosome complex, which mediates RNA surveillance and epigenetic regulation |
|
HIRA is not only critical for HBB expression but is also required for activation of the erythropoietic regulators KLF1 and GATA binding protein 1 (GATA1) |
|
KLF1 plays a role in facilitating and/or stabilizing GATA1 and TAL1 occupancy in the erythroid genes, contributing to the generation of active chromatin structure such as histone acetylation and chromatin looping |
|
GATA2 counteracts the erythroid-specific transcription factor GATA1, to modulate the proliferation and differentiation of hematopoietic cells |
|
TAL1 together with hematopoietic transcription factors RUNX1 and GATA1 binds to the promoter of the isoform 3 of PRKACB |
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
| somatic mutation
|  
|  
|  
|
in acute megakaryoblastic leukemia of Down syndrome | constitutional
| germinal mutation
|  
|  
|  
|
mutation, 332G --> C, in exon 2 of GATA1, leading to the synthesis of only the short isoform, leading by normal male to macrocytic anemia, normal platelet counts and neutropenia | tumoral
| somatic mutation
|  
|  
|  
|
associated with the myeloproliferative syndrome, transient (TAM) and the acute megakaryoblastic leukemia (AMKL) of Down syndrome | tumoral
| fusion
|  
|  
|  
|
MYB-GATA1 fusion gene in acute basophilic leukemia | |